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a b s t r a c t
Background: Parkinson disease (PD) results in severe limitation in ambulation caused by abnormality of
gait and posture. The rate of complications, including fractures and dislocation after total hip arthro-
plasty (THA), can be higher among these patients. The goal of this study was to investigate the long-term
outcomes of primary and revision THAs with cementless dual mobility implants.
Methods: This retrospective study examines 59 PD patients who had surgery between 2002 and 2012. All
the primary cases were performed for osteoarthritis and all patients received cementless acetabular
implants with dual mobility bearing surface. The femoral stem was cemented in 4 patients who
underwent revision surgery. The mean follow-up time was 8.3 years (4-14 years).
Results: Good to excellent pain relief was achieved in 53 of 57 patients at the 2-year follow-up and in 40
of 47 patients at their latest follow-up. The most common medical complication was cognitive impair-
ment (12 of 57 patients). One patient sustained an intraprosthetic hip dislocation 9 years after surgery,
which required revision. Four patients sustained periprosthetic femoral fractures with well-ﬁxed stem,
requiring open reduction and internal ﬁxation. The disability had increased in 68% of the patients in the
latest follow-up visit.
Discussion: Our study shows that elective primary or revision THA using cementless implants with dual
mobility bearing surface in patients with PD provides satisfactory long-term outcomes, although many of
these patients may see a general worsening of their activities over time due to PD.
© 2017 Elsevier Inc. All rights reserved.
Parkinson disease (PD) is a geriatric problem, which causes
severe limitation in the patients' ambulation, including abnor-
mality of gait and posture, and limited exercise capability. It af-
fects approximately 1% of the US population over 60 years old [1].
Many of these patients experience hip pain due to degenerative
joint disease that results in even more limitation of their mobility
and may require a total hip arthroplasty (THA). Postoperatively,
these patients may have higher rates of dislocation or
periprosthetic fractures due to PD-associated falls [2e4]. As a
result, orthopedic surgeons may hesitate to offer THA as a treat-
ment to these patients. Because of advances in arthroplasty
technology and the medical management of the PD, increasing
numbers of PD patients undergo THA.
Researchers have investigated outcomes of knee [5e10],
shoulder [11e15], and hip arthroplasties for hip fractures [16e18] in
this group of patients and reported high rates of complications and
dissatisfaction. Few studies are published about long-term out-
comes of THAs in PD patients [2e4,6].
The aim of this study was to report the long-term outcome of
THA using cementless dual mobility implants for primary and
revision surgeries in this group of patients.
Materials and Methods
This was a retrospective longitudinal study of patients whowere
diagnosed with PD and underwent THA in our hospital. Patients
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underwent surgery in the Department of Orthopaedic and Trauma
Surgery, Pitie-Salpe^triere Hospital, between 2002 and 2012. We
obtained approval from our institutional review board for this
study.
Our study population included 59 patients (34 men and 25
women). The average age at the time of surgery was 72.5 years
(range 55-79 years). The surgeries included 42 primary THAs for
osteoarthritis and 21 revision hip arthroplasties. The indication for
revision surgery included recurrent hip dislocation (11 hips), severe
acetabular polyethylene wear (6 hips), and femoral implant loos-
ening (4 hips). All surgeries were performed using an anterolateral
approach. In all primary surgeries, patients received a cementless
acetabular implant with dual mobility bearing surface (Concept
DM, Ceramconcept, Newark, DE). The highly cross-linked poly-
ethylene was not used in any of these patients. For primary THA
cases, patients received hydroxyapatite-coated, double-tapered
titanium stem (Monoblock Global stem [38 cases], Modular global
stem [4 cases], Ceramconcept, Newark, DE). A dual mobility bearing
surface was used in all revision cases. In 7 cases with recurrent hip
dislocation (7 of 11 hips), only the acetabular implant was changed,
whereas in the other 4 cases (4 of 11 hips), both the acetabular and
femoral implants were revised. In those hips that underwent
revision of the femoral implant (4 hips), the loose implant was
removed and the new femoral stem was cemented in place (Opti-
mum stem, Ceramconcept, Newark, DE). All patients were followed
up closely by neurology team and physical therapists perioper-
atively. All patients had normal physical therapy, which included
balance therapy. Patients were followed up for a mean of 8.3 years
(range 4-14 years). Two patients were lost to follow-up before their
2-year follow-up. Ten patients had passed away at the end of the
study because of unrelated medical reasons. This left 57 patients at
2-year follow-up and 47 patients at the latest follow-up.
The preoperative and postoperative PD-related disability was
deﬁned based on the Hoehn and Yahr classiﬁcation system [19].
This system was deﬁned in 1967 and is presented in Table 1.
Statistical Analysis
This was a retrospective case series study. We used Kaplan-
Meier methods to report the survival of the patients free of revi-
sion and reoperation. The preoperative and postoperative disability
status (based on Hoehn and Yahr classiﬁcation) was compared
using chi-square tests [19]. The statistical analysis was performed
with Stata 14.1 (StataCorp LP, College Station, TX).
Results
Good to excellent pain relief was achieved in 53 of 57 patients at
the 2-year follow-up and in 40 of 47 patients at their latest follow-
up. At the most recent follow-up, there was no clinical or radio-
graphic periprosthetic loosening of the cementless acetabular or
femoral implants or signiﬁcant polyethylenewear. Figure 1 shows a
patient who underwent primary THA and Figure 2 shows a patient
who underwent revision hip arthroplasty. Postoperative medical
complications included pneumonia (3 patients), urinary tract in-
fections (7 patients), cognitive impairment (12 patients), and sacral
pressure ulcers (2 patients). Postoperative surgical complications
included wound infection with Escherichia coli in 2 patients who
subsequently underwent irrigation and debridement with intra-
venous antibiotics (7 years and 9 years after index surgery). One
patient sustained intraprosthetic hip dislocation 9 years after
surgery, requiring revision surgery to exchange the dual mobility
head (Fig. 3). This patient had developed pelvic retroversion, which
resulted in posterior impingement, superoanterior polyethylene
wear, and as a result intraprosthetic dislocation. This patient
underwent revision of the modular stem to a new stem with less
anteversion. The acetabular implant was well ﬁxed and was not
revised. Four patients sustained periprosthetic femoral fractures
between 2 and 5 years from index surgery. None of the femoral
stems were loose. The fractures in 2 patients were Vancouver type
AG fracture and were treated with cables only. The fractures in the
other 2 cases were Vancouver type B1 fracture and were treated
with plates, screws, and cables. In survival analysis using Kaplan-
Meier method with revision, reoperation and dislocation as end
points, survival was 91.5% at the 2-year follow-up and 79.7% at the
5-year follow-up (Fig. 4).
According to the Hoehn and Yahr classiﬁcation [19], the
preoperative disability was classiﬁed to be stage 1 in 19 patients (of
59, 32.2%), stage 2 in 24 patients (of 59, 40.7%), and stage 3 in 16
patients (of 59, 27.1%). The postoperative disability was classiﬁed to
be stage 1 in 7 patients (of 47, 14.9%), stage 2 in 13 patients (of 47,
27.7%), stage 3 in 18 patients (of 47, 38.3%), and stage 4 in 9 patients
(of 47, 19.1%) (P < .001). In 16 patients (of 47, 34%), the disability
classiﬁcation had not changed. Twenty-four patients had wors-
ening in disability by 1 stage (of 47, 51.1%) and 7 patients had
worsening of their disability by 2 stages (of 47, 14.9%).
Discussion
Our results indicate that elective primary or revision THA using
dual mobility cementless cup and cementless femoral stem in pa-
tients with PD showed satisfactory outcomes in midterm to long-
term results. This study is one of the ﬁrst reports on the clinical
and radiographic assessment of elective primary or revision THA
with dual mobility cementless cup and cementless femoral stem
in patients with PD. The few studies that have been published on
this topic deal with primary and revision THAs in PD patients
performed for femoral neck fractures or for failed implants after
femoral neck fracture [1,2] and were not included in our work. In
our study, all patients experienced improvement in their pain in the
early follow-up and maintained the improvement of their pain at
the latest follow-up, even though, as expected, the disease pro-
gression of PD occurred in the long-term. Our results indicate that
successful primary and revision THA improves the pain and the
quality of life of patients with PD, even in those with signiﬁcant
disability and ultimate PD-associated death.
THA in patients with PD is a challenging surgery because of
associated comorbidity and complications. Previous studies
reported the high general and local complication rates in these
patients (2, 4). Our results indicate that 11 patients with primary
THA (29.7%) and 8 patients with revision THA (40.0%) had general
complications, consistent with previously publishedworks. Queally
et al [20] reported that aggressive medical management of patients
with PD in the early post-operative period helped to avoid com-
plications. Their results suggest that rehabilitation should be
Table 1
Hoehn and Yahr Classiﬁcation System for Disability.
Stage
1 Unilateral involvement only, usually with minimal or no functional
impairment.
2 Bilateral or midline involvement, without impairment of balance.
3 First sign of impaired righting reﬂexes. The patient is unsteady on
turning or when pushed from a standing position with the feet together
and eyes closed. Function is somewhat restricted, but some work may be
possible. Patients can lead independent lives with mild-to-moderate
disability.
4 Fully developed, severely disabling disease. The patient is able to walk
and stand unassisted, but is markedly incapacitated.
5 Conﬁnement to bed or wheelchair, unless aided.
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Fig. 1. Preoperative (A) and postoperative (B) EOS imaging (standing and sitting) in a patient with Parkinson disease and spinal deformity who underwent primary total hip
arthroplasty without complication.
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Fig. 2. Preoperative (A) and postoperative (B) EOS imaging (standing and sitting) in a patient with Parkinson disease who underwent revision total hip arthroplasty without
complication.
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Fig. 3. Preoperative (A) and postoperative (B) EOS imaging (standing and sitting) of a patient who sustained intraprosthetic dislocation of the femoral head after surgery. This
patient developed pelvic retroversion after total hip arthroplasty, which resulted in posterior impingement and superoanterior polyethylene wear. This patient underwent revision
surgery for a new dual mobility bearing surface and a femoral stem with less anteversion.
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started early to minimize complication and achieve the maximum
degree of physical activity.
According to the literature, the rate of dislocation after THA in
patients with PD is 0%-37% [2,21e23]. The neurological conditions
such as neuromuscular weakness can predispose patients to gait
disturbance, fall, functional disturbance, and dislocation after THA
[24]. PD patients are a high-risk group for dislocation after primary
and revision THAs because of increased muscle tone and rigidity
[23]. Using comprehensive nationwide Finnish health registry data,
Jamsen et al [6] reported recently that the rate of early hip dislo-
cation after primary THA increased signiﬁcantly (hazard ratio 2.33).
Strategies for managing dislocation after THA in high-risk patients
include the constrained liner, the large femoral head, large-
diameter metal-on-metal total hip prosthesis, and dual mobility
[3,21,25e31]. Therefore, since 2003, we have been using the dual
mobility implant in all patients with PD. In the present study of 57
PD patients, after elective primary and revision THAs, therewere no
dislocations at mean 8.3 years follow-up. Mohammed et al [26]
reported that there were no dislocations after primary and revi-
sion THAs using dual mobility implants in the patients with central
nervous system problems. Our ﬁndings in agreement with the
published results from these studies indicate that THA in the
patients with PD using dual mobility implants is one form of
treatment for achieving satisfactory outcomes. Our study shows
that cementless cups and femoral stems can be used with a very
low rate of mechanical complication. We did ﬁnd one asymptom-
atic patient with intraprosthetic dislocation who needs further
revision. This complication has been reported by others [32,33]. The
reason for this is not known. This patient had dislocation because of
developing pelvic retroversion over time. As a result, patient
sustained intraprosthetic dislocation because of posterior
impingement. We advise that the surgeon should be aware of the
possibility of intraprosthetic dislocation after dual mobility
implant. Also, it is critical to assess the changes in pelvic version in
standing and sitting positions and adjust the implant orientation
accordingly.
Previous reports of the outcome of THA in PD patients indicate
that acetabular and femoral component ﬁxation in THA can be
achieved using cemented devices [2,4,6]. A recent meta-analysis
concluded that PD patients were at higher risk of osteoporosis
than healthy control subjects (OR 2.61) [34]. In elderly patients with
osteoporosis, cemented prostheses provide initial stability and
immediate weight-bearing ambulation. A recent report indicated
that short-term result of THA using cementless dual mobility
implant in patients with PD reduced dislocation without increased
risk of loosening [26]. In our study, none of the patients had an
intraoperative periprosthetic fracture and any subsequent insta-
bility or further revision because of loosening. However, there were
2 (5.4%) and 2 (10.0%) periprosthetic fracture after primary and
revision THA, respectively. These patients were injured because of
fall. Mathew et al [4] reported that the 2 patients (13.3%) of 15 PD
patients had a periprosthetic fracture after THA. In PD patients,
fragility fractures caused by poor bone quality and falls because of
the disturbed postural reﬂex [35]. The treatment of periprosthetic
femoral fracture after femoral revision is more complex and chal-
lenging [36]. These results suggested that elective primary or
revision THA using dual mobility cementless cup and cementless
femoral stem in patients with PD were satisfactory midterm to
long-term results. Because of the nature of their medical condition,
PD patients after THA should be managed with neurologist and
continue the rehabilitation to prevent postoperative periprosthetic
femoral fracture.
There were several limitations to this study. First, this study was
retrospective without a patient control group for comparison.
Second, our patient population is rather small, but it is more than
some of the previously published studies. Third, our study did not
include any patients who underwent THA due to femoral neck
fracture. This, in addition to the fact that this group of patients is
low demand with limited activity may explain rather good results
on a mean follow-up in our study.
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